BPG is committed to discovery and dissemination of knowledge
Featured Articles
5/7/2021 12:36:57 PM | Browse: 795 | Download: 1760
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 63373
Country Italy
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Liquid biopsy in cholangiocarcinoma: Current status and future perspectives
Manuscript Source Invited Manuscript
All Author List Gianluca Rompianesi, Marcello Di Martino, Alex Gordon-Weeks, Roberto Montalti and Roberto Troisi
Funding Agency and Grant Number
Corresponding Author Gianluca Rompianesi, FEBS, MD, PhD, Assistant Professor, Surgeon, Hepato-Bilio-Pancreatic, Minimally Invasive and Robotic Surgery Unit, Department of Clinical Medicine and Surgery, Federico II University Hospital, via S. Pansini 5, Napoli 80131, Italy. gianlucarompianesi@gmail.com
Key Words Liquid biopsy; Cholangiocarcinoma; Circulating biomarkers; Biliary tumors; Circulating DNA; Circulating RNA; Exosomes; Cytokines
Core Tip Liquid biopsy represents allows to access tumoral components and genetic material from fluid samples. In patients affected by cholangiocarcinoma could play a major role as minimally invasive screening and diagnostic biomarkers, prognostic tools and therapeutic monitoring targets but its role in the clinical practice is still marginal and further research is necessary.
Publish Date 2021-05-07 09:15
Citation Rompianesi G, Di Martino M, Gordon-Weeks A, Montalti R, Troisi R. Liquid biopsy in cholangiocarcinoma: Current status and future perspectives. World J Gastrointest Oncol 2021; 13(5): 332-350
URL https://www.wjgnet.com/1948-5204/full/v13/i5/332.htm
DOI https://dx.doi.org/10.4251/wjgo.v13.i5.332
Full Article (PDF) WJGO-13-332.pdf
Full Article (Word) WJGO-13-332.docx